Hillege, H. L. et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14), 1777–1782 (2002).
Siddiqi, F. S. & Advani, A. Endothelial-podocyte crosstalk: The missing link between endothelial dysfunction and albuminuria in diabetes. Diabetes 62(11), 3647–3655 (2013).
Hanna, D. B. et al. Association of albuminuria with cardiac dysfunction in US Hispanics/Latinos. Am. J. Cardiol. 119(12), 2073–2080 (2017).
Wang, J. et al. Reduced kidney function, albuminuria, and risks for all-cause and cardiovascular mortality in China: A population-based cohort study. BMC Nephrol. 18(1), 1–9 (2017).
Pavkov, M. E., Knowler, W. C., Hanson, R. L., Bennett, P. H. & Nelson, R. G. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am. J. Kidney Dis. 51(5), 759–766 (2008).
Szczech, L. A. et al. Microalbuminuria in HIV infection. AIDS (London, England) 21(8), 1003 (2007).
Choi, A. et al. Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am. J. Kidney Dis. 56(5), 872–882 (2010).
Gupta, S. K., Shen, C., Mather, K. J., Agarwal, R. & Dubé, M. P. Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension. J. Infect. Dis. 204(12), 1946–1950 (2011).
Kramer, H. M., Hsu, C. Y. & Curhan, G. Need for sex specific ACR. Am. J. Kidney Dis. 40(2), 435–436 (2002).
Nowacki, A. Chi-square and Fisher’s exact tests. Clevel. Clin. J. Med. 84, E20–E25 (2017).
MacFarland, T. W. & Yates, J. M. Mann–Whitney U test. In Introduction to Nonparametric Statistics for the Biological Sciences Using R 103–132 (Springer, 2016).
Günther, A. & Höfler, M. Different results on tetrachorical correlations in Mplus and Stata-Stata announces modified procedure. Int. J. Methods Psychiatr. Res. 15(3), 157–166 (2006).
Draper, N. R. & Smith, H. Applied Regression Analysis (Wiley, 1998).
Wensink, G. E. et al. Albuminuria is associated with traditional cardiovascular risk factors and viral load in HIV-infected patients in rural South Africa. PLoS One 10(8), e0136529 (2015).
Kiggundu, T., Kalyesubula, R., Andia-Biraro, I., Makanga, G. & Byakika-Kibwika, P. Prevalence of microalbuminuria and associated factors among HIV-infected ART naïve patients at Mulago hospital: A cross-sectional study in Uganda. BMC Nephrol. 21(1), 1–6 (2020).
Lin, C. C. et al. Gender difference in the relationship of albuminuria and arterial stiffness in Chinese adults—A 6.6-year follow-up longitudinal study. Kidney Blood Pressure Res. 43(5), 1479–1487 (2018).
Fabian, J. & Naicker, S. HIV and kidney disease in sub-Saharan Africa. Nat. Rev. Nephrol. 5(10), 591–598 (2009).
Friis-Møller, N. et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 17(8), 1179–1193 (2003).
Cailhol, J. et al. Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: A cross-sectional study. BMC Nephrol. 12(1), 1–9 (2011).
Szczech, L. A. et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 61(1), 195–202 (2002).
Han, T. M., Naicker, S., Ramdial, P. K. & Assounga, A. G. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 69(12), 2243–2250 (2006).
Peters, P. J. et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 74(7), 925–929 (2008).
Arendse, C. G., Wearne, N., Okpechi, I. G. & Swanepoel, C. R. The acute, the chronic and the news of HIV-related renal disease in Africa. Kidney Int. 78(3), 239–245 (2010).
Cohen, S. D. & Kimmel, P. L. HIV-associated renal diseases in Africa—A desperate need for additional study. Nephrol. Dial. Transplant. 22(8), 2116–2119 (2007).
Stehouwer, C. D. & Smulders, Y. M. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J. Am. Soc. Nephrol. 17(8), 2106–2111 (2006).
Thienemann, F., Sliwa, K. & Rockstroh, J. K. HIV and the heart: The impact of antiretroviral therapy: A global perspective. Eur. Heart J. 34(46), 3538–3546 (2013).
Jang, M. et al. Differences in factors associated with albuminuria according to gender and comorbidities of hypertension and diabetes. Korean J. Family Med. 36(6), 316 (2015).
Mocroft, A. et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 24(11), 1667–1678 (2010).
Kim, P. S. et al. Increased prevalence of albuminuria in HIV-infected adults with diabetes. PLoS One 6(9), e24610 (2011).
Khoza, S. P., Crowther, N. J. & Bhana, S. The effect of HIV infection on glycaemia and renal function in type 2 diabetic patients. PLoS One 13(6), e0199946 (2018).
Djiby, S. et al. Prevalence of microalbuminury and associated risk factors in a population of diabetics followed at the Marc Sankale Center of Dakar. Open J. Intern. Med. 8(1), 24–32 (2018).
Falasca, K. et al. Predictive factors and prevalence of microalbuminuria in HIV-infected patients: A cross-sectional analysis. BMC Nephrol. 18(1), 1–8 (2017).
Wyatt, C. M. et al. Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: Data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. J. Acquir. Immune Defic. Syndr. 67(1), 36 (2014).
Assaram, S., Magula, N. P., Mewa Kinoo, S. & Mashamba-Thompson, T. P. Renal manifestations of HIV during the antiretroviral era in South Africa: A systematic scoping review. Syst. Rev. 6(1), 1–11 (2017).
Xie, N. et al. Association of systolic blood pressure and pulse pressure with microalbuminuria in treatment-naïve hypertensive patients. Arch. Med. Sci. AMS 15(4), 832 (2019).
Ene-Iordache, B. et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): A cross-sectional study. Lancet Glob. Health 4(5), e307–e319 (2016).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41598-024-65099-w